ARCHIVES

NCI Advisory Group, Other Cancer Meetings

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

In Brief: Wells, Gardner, Brennan Lead Surgical Oncology; Young, Flynn, Are New officers For Head & Neck

March 26, 1993

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

Combination Skin Treatments Reduce Rash From Vectibix

June 26, 2009

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

December 4, 1998